Target intelligence / Profile preview

Streptococcus mutans glucan-binding protein (GBP) (GBP)

Target
GBP
Molecular classification
Bacterial surface protein, Lectin, Adhesin, Peptidoglycan hydrolase
01

Overview

Streptococcus mutans glucan-binding proteins (GBPs) are a family of secreted and cell-surface proteins, including GbpA, GbpB, GbpC, and GbpD, that play a pivotal role in the development of dental caries [2, 3, 4]. These proteins facilitate the adherence and accumulation of S. mutans on tooth surfaces by binding to glucans, which are glucose polymers synthesized from dietary sucrose by glucosyltransferases [4, 18]. GbpC acts as a primary cell-surface receptor for glucan, mediating bacterial aggregation, while GbpB is an essential protein involved in cell wall maintenance and division [4, 11, 13]. By promoting the formation of a robust extracellular matrix and stable biofilm architecture, GBPs enable the bacteria to resist mechanical clearance and host immune responses [12, 18]. Due to their critical role in bacterial virulence and survival, GBPs are prominent targets for the development of anti-caries vaccines and small-molecule inhibitors [13, 15]. Therapeutic strategies targeting these proteins aim to disrupt biofilm formation and reduce the cariogenic potential of S. mutans without necessarily eliminating the entire oral microflora [15].

Other names
GbpAGbpBGbpCGbpDGlucan-binding proteinDextran-binding proteinGlucan receptorGBP receptor site
02

Mechanism of action

Inhibition of bacterial accumulation and biofilm formation by blocking glucan-protein interactions or disrupting cell wall synthesis.

03

Biological functions

Biofilm formationBacterial adhesionCell wall maintenanceCell divisionDextran-dependent aggregation
04

Disease associations

Dental cariesInfectionBacteremia
05

Safety considerations

Potential for antibiotic resistanceImpact on oral microbiome diversitySpecificity for S. mutans over commensal streptococci
06

Interacting drugs

Experimental GbpB vaccine

3 more in the full profile.

07

Biomarkers

Salivary IgA antibodies against GbpB

Beyond the preview

Go deeper on Streptococcus mutans glucan-binding protein (GBP) (GBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus mutans glucan-binding protein (GBP) (GBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call